Buy Rating Reaffirmed for TRACON Pharmaceuticals Post-Reverse Split and Envafolimab Valuation Update
Analysts Offer Insights on Healthcare Companies: TRACON Pharmaceuticals (TCON) and IN8bio (INAB)
TRACON Pharma Analyst Ratings
JonesTrading Reaffirms Their Hold Rating on TRACON Pharmaceuticals (TCON)
Buy Rating for TRACON Pharmaceuticals on Strong Financials and Promising Clinical Trials
TRACON Pharma Analyst Ratings
Buy Rating for TRACON Pharmaceuticals on Envafolimab's Promising Trial Outcomes and Strong Market Potential
HC Wainwright & Co. Reiterates Buy on TRACON Pharma, Maintains $7 Price Target
TRACON Pharma Analyst Ratings
Analysts Offer Insights on Healthcare Companies: TRACON Pharmaceuticals (TCON), Anavex Life Sciences (AVXL) and Genmab (GMAB)
Promising Financial and Clinical Prospects Bolster Buy Rating for TRACON Pharmaceuticals
Buy Rating for TRACON Pharmaceuticals Backed by Positive Q3 Results, Financial Sustainability, and Promising Drug Trial Progress
Analysts Offer Insights on Healthcare Companies: Xenon (XENE) and TRACON Pharmaceuticals (TCON)
TRACON Pharma Analyst Ratings
JonesTrading Downgrades TRACON Pharmaceuticals (TCON) to a Hold
Analysts Are Bullish on Top Healthcare Stocks: TRACON Pharmaceuticals (TCON), Alcon (ALC)
TRACON Pharma Analyst Ratings
TRACON Pharmaceuticals (TCON) Receives a Buy From JonesTrading
Baird Trims Price Target on TRACON Pharmaceuticals to $7 From $8, Maintains Outperform Rating
Baird Maintains Outperform on TRACON Pharma, Lowers Price Target to $7
No Data